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Abstract
Caveolin-1 is known to promote cell migration, and increased caveolin-1 expression is associated with tumor progression
and metastasis. In fibroblasts, caveolin-1 polarization and phosphorylation of tyrosine-14 are essential to promote
migration. However, the role of caveolin-1 in migration of metastatic cells remains poorly defined. Here, caveolin-1
participation in metastatic cell migration was evaluated by shRNA targeting of endogenous caveolin-1 in MDA-MB-231
human breast cancer cells and ectopic expression in B16-F10 mouse melanoma cells. Depletion of caveolin-1 in MDA-MB-
231 cells reduced, while expression in B16-F10 cells promoted migration, polarization and focal adhesion turnover in a
sequence of events that involved phosphorylation of tyrosine-14 and Rac-1 activation. In B16-F10 cells, expression of a non-
phosphorylatable tyrosine-14 to phenylalanine mutant failed to recapitulate the effects observed with wild-type caveolin-1.
Alternatively, treatment of MDA-MB-231 cells with the Src family kinase inhibitor PP2 reduced caveolin-1 phosphorylation
on tyrosine-14 and cell migration. Surprisingly, unlike for fibroblasts, caveolin-1 polarization and re-localization to the
trailing edge were not observed in migrating metastatic cells. Thus, expression and phosphorylation, but not polarization of
caveolin-1 favor the highly mobile phenotype of metastatic cells.
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Introduction
Cell migration is essential in a large variety of biological
processes, including embryonic development, tissue repair and
regeneration, as well as events associated with diseases like
arthritis, atherosclerosis and tumor cell metastasis [1]. Initially,
cells respond to external cues (wounding, chemokines and growth
factors) by reorientation of the microtubule organizing center
(MTOC) and Golgi toward the leading edge (cell polarization step)
[2]. Then, cells extend broad (lamellipodia) and spike-like protru-
sions (filopodia) in a process that is followed by focal adhesion (FA)
formation, cell body contraction and finally retraction of the rear
end by severing FAs [3]. Many of these events are organized by
the Rho family of small GTPases, which includes RhoA, Rac1 and
Cdc42. Signals that activate Rho GTPases lead to spatiotemporal
regulation of FA assembly, dynamics and turnover [4,5].
Many proteins including PI3K, PTEN [6], Rho-GTPases [4,7]
and caveolin-1 [8,9], have been shown to re-distribute throughout
the cell during polarized migration. Caveolin-1 is of special
interest, since it is known to promote cell migration [10], invasion
[11,12,13] and is proposed to be involved in tumor cell metastasis
(reviewed in [14,15]).
Caveolin-1 is an integral membrane protein involved in
caveolae biogenesis, cholesterol homeostasis, intracellular traffick-
ing and signal transduction, amongst other functions (reviewed in
[15]). The precise role of caveolin-1 in tumorigenesis remains a
matter of intense debate and whether the protein acts as a tumor
suppressor or as a promoter of metastasis seems to be cell type and
context-dependent [14,15]. Thus, in cancer models including
prostate, breast and colon, caveolin-1 expression is known to be
up-regulated and protein levels correlate with tumor progression
and metastasis [15]. Consistent with a role in metastasis, caveolin-
1 was reported to enhance cell migration and invasiveness
[11,12,16,17]. However, the role of caveolin-1 during cell
migration has been mostly characterized in non-metastatic cells.
For instance, in mouse embryonic fibroblasts (MEFs), caveolin-1-
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velocity and persistency of cell migration [18]. In addition,
caveolin-1 decreases Rac1 and Cdc42, but increases RhoA activity
by inhibiting the Src/p190RhoGAP signaling pathway [10,18].
Intriguingly, caveolin-1 itself accumulates at the rear of migrating
fibroblasts, neurons and endothelial cells in 2D models [19,20,21],
although in transmigrating endothelial cells and neurons, caveolin-
1 preferentially accumulates at the cell front [20,22]. Caveolin-1-
dependent cell migration and accumulation at the rear of MEFs
require the aminoacid sequence 1-60, which encompasses a
putative N-terminal caveolin-1 polarization domain [21,23].
Caveolin-1 stabilizes the focal adhesion kinase (FAK) at FAs by
decreasing the shuttling between FAs and cytosolic pools, as shown
by fluorescence recovery after photobleaching analysis of the
mobile fraction. Since FAK, and more specifically phospho-Y397-
FAK, is known to enhance FA turnover, caveolin-1 was suggested
to participate in the regulation of this process [24]. Indeed,
subsequent studies showed that caveolin-1-dependent stabilization
of FAK, cell migration and invasion involved the Src/Rho/
ROCK axis as well as phosphorylation of caveolin-1 on tyrosine-
14 [11]. Rather intriguingly, caveolin-1 was also shown to increase
the stability of nascent FAs (or focal contacts) and RhoA activation
[18].
Interestingly, Src kinase-mediated phosphorylation of caveolin-1
on tyrosine-14 appears to be essential for caveolin-1-driven cell
migration. In metastatic breast cancer cells (MDA-MB-231),
caveolin-1 is highly expressed and phosphorylated on tyrosine-
14, in comparison to non-metastatic cancer cells [11]. Although
initial studies suggested a putative role for caveolin-1 phosphor-
ylation on tyrosine-14, controversial issues remain regarding the
precise involvement of phospho-caveolin-1 in adhesion com-
plexes with the extracellular matrix [25]. Most importantly,
however, the role of caveolin-1 in migration of metastatic cells
requires further investigation in order to understand how this
protein may contribute to processes like metastasis.
In this study, we specifically investigated the role of caveolin-1 in
metastatic cell migration by employing two different models:
MDA-MB-231 human breast cancer cells and the mouse
melanoma cell line B16-F10. In both cell lines, caveolin-1
promoted cell migration by increasing FA turnover, polarization,
velocity, persistence and directionality. These functions of
caveolin-1 are all blocked by interfering with phosphorylation on
tyrosine-14, as shown by pharmacological inhibition and muta-
tional analysis. Intriguingly, in both metastatic cell models,
caveolin-1 localization to the cell rear was not required to
promote migration.
Results
Caveolin-1 Accumulates at the Trailing Edge of Migrating
MEF-3T3 and DI-TNC1 Cells, but not Metastatic MDA-MB-
231 and B16-F10 Cells
Previous studies have shown that caveolin-1 accumulates at the
rear of migrating cells including MEFs, HUVECs and neurons
[19,20,21]. We sought to extend these observations to rapidly
migrating metastatic cells, by assessing the localization of caveolin-
1 in a wound-healing assay followed by immunofluorescence
analysis. The human breast cancer cell line MDA-MB-231 and
DI-TNC1, as well as MEF-3T3 cells, all expressed high
endogenous levels of caveolin-1 (Figure 1A). Unexpectedly,
caveolin-1 failed to accumulate at the rear of MDA-MB-231 cells
during migration towards the wounded area (Figure 1B). In
agreement with previous reports [8,9], polarization of caveolin-1
was detected in MEF-3T3 fibroblast cells, as well as in astrocytic
DI-TNC1 cells (Figure 1B). To evaluate the extent of caveolin-1
polarization, fluorescence intensities at the rear and front were
quantified within discrete zones using the Image J software and the
rear/front ratios were calculated at different time points of
migration, as previously described [21,23]. For both MEF-3T3
and DI-TNC1, but not MDA-MB-231 cells, time-dependent
increases in caveolin-1 polarization were detected, whereby
accumulation at the rear was almost complete after 360 minutes
of migration (Figure 1C). Lack of caveolin-1 polarization in MDA-
MB-231 cells could not be attributed to high endogenous
expression levels in these cells, since, following shRNA-mediated
down-regulation of caveolin-1, remnant caveolin-1 failed to
polarize in these cells upon migration (see text below,
Figures 2A, 2B and 2C).
To extend our findings in MDA-MB-231 cells, caveolin-1
polarization was also evaluated in mouse melanoma B16-F10 cells.
These cells express low endogenous levels and, therefore, caveolin-
1 was introduced by stably transfecting cells with the placIOP
plasmid containing an insert encoding the full-length protein. An
advantage of this plasmid is that it permits IPTG-inducible
expression [26]. As shown, transfection with pLacIOP-caveolin-1
(cav1 condition) led to a 5-fold increase in caveolin-1 levels when
compared with cells transfected with the empty vector pLacIOP
(mock condition, Figure 1D). Expression was further increased with
1mM IPTG by another 5-fold when compared to non-induced
cells (Figure 1D). Thus, caveolin-1 localization was evaluated in
both induced (high expression) and non-induced cells (low
expression) upon migration in a wound-healing assay. As for
MDA-MB-231 cells, caveolin-1 failed to re-localize in migrating
B16-F10 cells (Figure 1E) and accumulation at the rear was never
observed at any time during migration (Figure 1F).
Taken together, these results suggest that, contrary to
observations in non-metastatic cells evaluated here (MEF-3T3,
DI-TNC1) and in the literature [19,20,21], caveolin-1 does not
undergo polarization during migration of metastatic cells. Since
the consequences of such caveolin-1 behavior for cell migration
are unknown, the contribution of caveolin-1 to several migration-
associated characteristics of MDA-MB-231 and B16-F10 cells was
evaluated in the following experiments.
Cell polarization is the first step required for cell migration
and directional movement. Re-localization of the MTOC ahead
of the nuclei and behind the Golgi is important in defining the
direction of migration [27]. To examine the role of caveolin-1
in MDA-MB-231 cell polarization, endogenous protein was
down-regulated by shRNA (shRNA-caveolin-1 #5) (Figure 2A).
As observed in Figure 1, residual endogenous caveolin-1 did not
accumulate at the rear of migrating cells (Figures 2B, 2C).
However, polarization of MDA-MB-231 cells with decreased
caveolin-1 expression was substantially reduced, as shown by
Golgi orientation (Figures 2B, 2D; Figure S1A, S1B). Quanti-
tative analysis indicated that shRNA-mediated down-regulation
of caveolin-1 delayed MDA-MB-231 cell polarization, since
differences were no longer significant after 360 minutes
(Figure 2D). As might be predicted for a dose-dependent
caveolin-1 effect, partial loss of cell polarization was observed
with another shRNA (shRNA-caveolin-1, sequence#3) that
targeted caveolin-1 with lower efficiency (Figure S1A, Figure
S1C). Thus, caveolin-1 appears to play an early, but transient
role in the polarization of metastatic MDA-MB-231 cells.
Likewise, B16-F10 cell polarization increased in a time-
dependent fashion upon migration into a wounded area and
the number of polarized cells was substantially higher in
caveolin-1 expressing cells following IPTG induction (Figures 2E,
2F; Figure S2). A smaller increase in cell polarization was
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when compared with the mock control (Figure 2F). These
results indicate that in both B16-F10 mouse melanoma and
MDA-MB-231 human breast cancer cells, caveolin-1 promotes
cell polarization in a manner that does not require caveolin-1
accumulation at the cell rear.
Caveolin-1 Promotes Migration of Metastatic Cells
The role of caveolin-1 in cell migration is controversial and
appears to be cell-context dependent, since it has been described
both as a positive [18,19] and negative regulator of migration
[28,29,30]. In these studies predominantly fibroblasts and
endothelial cells were characterized. Thus, we evaluated the effect
Figure 1. Caveolin-1 fails to accumulate at the trailing edge of migrating metastatic cells. (A) Total protein extracts from DI-TNC1, MEF-
3T3 and MDA-MB-231 cells were separated by SDS-PAGE (35 mg total protein per lane) and analyzed by Western Blotting with antibodies against
caveolin-1 and b-actin. (B) Confluent monolayers of DI-TNC1, MEF-3T3 and MDA-MB-231 cells were wounded with a pipette tip and fixed at 0 (left
panel) and 60 minutes (right panel) after monolayer injury. Cells were stained with a rabbit polyclonal anti-caveolin-1 antibody followed by an anti-
rabbit IgG antibody (green) and nuclei were visualized with DAPI (blue). The first layer of cells facing the wounded area is distinguished from the rest
by a white line. Scale bar, 20 mm. (C) Caveolin-1 distribution was evaluated by measuring the fluorescence intensity in four randomly chosen regions
of equal dimensions at the front and the rear of the cell with the Image J software, as detailed in the Materials and Methods. Data represent the ratio
of fluorescence intensity ‘‘rear/front’’ (mean 6 SEM; n= 3). Statistically significant differences compared with time 0 minutes for each cell type are
indicated (**, P,0.01; *, P,0.05). (D) B16-F10 cells transfected with either pLacIOP (mock) or pLacIOP-caveolin-1 (cav1) were treated or not with 1mM
IPTG for 24 hours and total protein extracts were prepared, separated by SDS-PAGE (35 mg total protein per lane) and analyzed by Western Blotting.
(E) Confluent monolayers of pLacIOP-caveolin-1 transfected B16-F10 cells in the absence or presence of 1mM IPTG were wounded with a pipet tip
and fixed either at 0 or 60 minutes after wounding. Samples were stained with anti-caveolin-1 polyclonal antibody (green) and DAPI (blue). The edge
of the wound is outlined with a white line. Scale bar, 20 mm. (F) Caveolin-1 localization was analyzed at different time points, as described in C. Data
are the mean 6 SEM from three independent experiments.
doi:10.1371/journal.pone.0033085.g001
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F10 cells. In both cases, caveolin-1 expression favored migration,
as observed in a Boyden Chamber assay (Figures 3A, 4A) and
upon analysis by time-lapse video microscopy combined with
individual cell tracking (Figures 3B, 4B). Caveolin-1 down-
regulation in MDA-MB-231 cells by shRNA decreased track
length and directionality of migration when compared with
parental and control cells (Figure 3B). The data support the idea
that caveolin-1 presence in these cells favors persistence of cell
migration. Indeed, caveolin-1 down-regulation decreased cell
migration associated parameters, including instant (Figure 3C)
and mean velocity (Figure 3D), persistency (obtained as the ratio
between net and total distance, Figure 3E) and directionality of
migration (expressed as the percentage of cells that move within a
60u angle from the starting point) (Figures 3B, 3F). Similar results
were obtained in B16-F10 cells, where caveolin-1 expression
increased transmigration in a Boyden Chamber assay (Figure 4A)
and migration in a wound-healing assay (Figure 4B), as well as the
instant and mean velocity, persistency and directionality of
migration (Figure 4C, Figure S3). These data are in agreement
with previous observations in MEF-3T3 cells [10,11,18] and
suggest that caveolin-1 modulates the migration of metastatic
MDA-MB-231 and B16-F10 cells, but does so even in the absence
of changes in intracellular distribution.
Figure 2. Polarization of metastatic cells is dependent on caveolin-1. (A) Total protein extracts were prepared from both parental MDA-MB-
231 and cells stably transduced with a control shRNA targeting luciferase (sh-ctrl) or a shRNA targeting caveolin-1 (shRNA-caveolin-1 #5, sh-cav1).
Extracts were separated by SDS-PAGE (35 mg total protein per lane) and analyzed by Western Blotting with antibodies against caveolin-1 and b-actin.
(B) Confluent monolayers of parental, shRNA-control (sh-ctrl) or shRNA-caveolin-1 (sh-cav1) treated MDA-MB-231 cells were wounded with a pipet tip
and fixed at 0 (left panel) and 60 minutes (right panel) after monolayer injury. Samples were stained with anti-caveolin-1 (green) and anti-Golgin-97
(red) antibodies, whereas the nuclei were stained with DAPI (blue). The first layer of cells facing the wounded area is distinguished from the rest by a
white line. Scale bar, 20 mm. (C) Caveolin-1 localization was analyzed as described in Figure 1C, by measuring the ratio of fluorescence intensity ‘‘rear/
front’’. Data are the mean 6 SEM, n=3. (D) Polarization of both parental (-) and shRNA treated MDA-MB-231 cells with shRNA-luciferase (sh-ctrl) or
shRNA-caveolin-1 (sh-cav1) was measured from (C) as described in the Materials and Methods, by analyzing the outer layer of cells facing the
wounded area (B). The percentage of polarized cells was evaluated at 0, 60 and 360 minutes after wounding. Data were averaged from three
independent experiments (mean 6 SEM). *Comparison with control shRNA P,0.05. (E) B16-F10 cells transfected with either pLacIOP (mock) or
pLacIOP-caveolin-1 (cav1) were treated or not with 1mM IPTG for 24 hours, grown in monolayers and wounded with a pipet tip to allow migration for
1 hours. Samples were stained with anti-Gigantin-1 polyclonal antibody (blue), phalloidin-Alexa488H (green) and propidium iodide (red). The outer
layer of cells facing the wounded area is outlined with a white line. (F) Cell polarization was measured as described in the Materials and Methods, by
analyzing the outer layer of cells facing the wounded area. The percentage of polarized cells was evaluated 0-360 minutes after wounding the
monolayer. Data were averaged from three independent experiments (mean 6 SEM). Statistically significant differences compared with pLacIOP-
transfected B16-F10 (mock) cells are indicated (**, P,0.01 at time 360 min; *, P,0.05 at time 60 min).
doi:10.1371/journal.pone.0033085.g002
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Migration of Metastatic Cells
Caveolin-1 undergoes Src-mediated phosphorylation on tyro-
sine-14, which is thought to be essential for fibroblast cell
migration [18]. The involvement of phosphorylation of caveolin-
1 on tyrosine-14 in promoting cell migration is further supported
by observations in breast cancer cell lines, including MDA-MB-
231 cells [11]. Thus, we evaluated the role of tyrosine
phosphorylation in the B16-F10 melanoma cell line. Intriguingly,
expression of non-phosphorylatable caveolin-1 (mutant Y14F)
failed to promote B16-F10 cell migration (Figure 4A, 4B).
Although the Y14F mutant was not expressed to the same extent
asthewildtypeprotein,itisunlikelythatsuchdifferentialexpression
accounts for inability of this protein to promote cell migration
(Figure 4A), since for a population of B16F10(caveolin-1) cells
Figure 3. Caveolin-1 favors directionality and persistence of migration in MDA-MB-231 cells. (A) Migration of MDA-MB-231 cells treated
with shRNA targeting either luciferase (sh-ctrl) or caveolin-1 (sh-cav1) was assessed in a Boyden chamber assay. Cells (5610
4) were seeded on
fibronectin-coated (2 mg/ml) transwell plates and allowed to migrate for 2 hours. Cells that migrated to the lower side were detected with crystal
violet staining (mean 6 SEM, n=3). **P,0.01. (B) Parental and shRNA treated MDA-MB-231 cells were grown as confluent monolayers, wounded
with a pipet tip and migration was recorded by time-lapse video microscopy (total 15 hours, 12 minutes frame interval). Cell tracks were determined
by using the Image J software (‘‘Manual Tracking’’ plug-in). Tracks of single cells at the wounded edge are shown (upper panel). The edge of the
wound is indicated with a white line. Single cell tracks are shown in a Cartesian coordinate system for each cell type (lower panel). (C) Instant velocity
was analyzed for each cell type in (B) and plotted as a function of time (0-15 hours). (D) Mean velocity values were obtained from (C) and plotted for
each cell type. (E) Persistency of migration was calculated as the ratio between the net distance and the total distance of migration in (B). Average
values were obtained for parental, sh-ctrl and sh-cav1 cells (mean 6 SEM). (F) Directionality of migration was obtained from the analysis shown in (B),
lower panels. Tracks that lay within a 60u angle with respect to the direction of cell movement were considered as oriented (shaded region). The
percentage of cells with orientated tracks was calculated and plotted (mean 6 SEM, n=3). *P,0.05.
doi:10.1371/journal.pone.0033085.g003
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in caveolin-1(Y14F) cells (see Figure S3), migration rates were
similar to those detected for the original population of
B16F10(caveolin-1) cells (Figure 4A). Video microscopy analysis
showed that tracks of mock controls and caveolin-1(Y14F) cells
were shorter than those obtained from cells expressing wild-type
caveolin-1 (Figure 4B). Additionally, migration was more
random in cells lacking caveolin-1 or expressing caveolin-
1(Y14F) and parameters of mean velocity, persistency and
directionality of migration were lower in caveolin-1(Y14F) cells
when compared with cells expressing wild-type caveolin-1
(Figure 4C). These results indicate that caveolin-1 promotes
cell migration in B16-F10 cells by increasing cell polarization,
velocity, persistency and directionality of cell movement and
that the ability to do so depends on the presence and
presumably phosphorylation of tyrosine-14.
Data obtained in B16-F10 cells were further validated by
pharmacological inhibition of the Src family kinases, which
phosphorylate caveolin-1 on tyrosine-14 [31]. Cell migration and
phosphorylation of caveolin-1 were evaluated in the presence
or absence of the selective Src kinase inhibitor, PP2 (4-amino-5-
(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine), in
both MDA-MB-231 and B16-F10 cells. Serum stimulation
increased wound closure in both MDA-MB-231 and B16-F10
cells. Wound closure was modulated by caveolin-1 expression, as
shRNA mediated down-regulation in MDA-MB-231 cells
decreased (Figure 5A, histogram bars), whereas ectopic expres-
sion in B16-F10 cells increased wound closure (Figure 5B,
histogram bars). Importantly, treatment with PP2, but not
control vehicle (dimethyl sulfoxide, DMSO) prevented caveolin-
1-enhanced wound closure in both MDA-MB-231 (Figure 5A)
and B16-F10 cells (Figure 5B). Moreover, both endogenous and
ectopically expressed caveolin-1 failed to undergo phosphoryla-
tion in the presence of this inhibitor (Figures 5A, 5B, Western
blots). It should be noted that little pY14-caveolin-1 was
detectable in the mock-transfected B16-F10 cells, presumably
because endogenous levels of caveolin-1 were too low. Impor-
tantly, no significant changes in proliferation were observed for
both cell lines in presence of the inhibitor (data not shown).
These results are consistent with the idea that the ability of
caveolin-1 to enhance metastatic cell migration depends on
tyrosine-14 phosphorylation by Src family kinases.
Caveolin-1 Promotes Focal Adhesion Turnover in
Metastatic Cells
Caveolin-1 decreases the shuttling of FAK between focal
adhesion and cytosolic pools, suggesting a role for caveolin-1 in
the turnover of FAs [24]. Most importantly, cell migration is
tightly regulated at the level of FA turnover [32,33]. Thus, we
evaluated the effect of caveolin-1 on FA turnover in metastatic
cancer cells by transfection with GFP-vinculin followed by time-
lapse videomicroscopy analysis. GFP-vinculin was associated with
FAs of both mock and caveolin-1 expressing B16-F10 cells
(Figure 6A). Although a small percentage of total FAs underwent
turnover in B16-F10 cells (5–10% of total FAs), a significant
increase in the kinetics of FA disassembly was observed in
caveolin-1 expressing cells when compared with the mock control
(Figure 6A, arrows; Figure 6B, top graph). Importantly, expression
of caveolin-1 increased focal contact (FC) lifetime (Figure 6A,
arrowheads; Figure 6B, bottom graph), in agreement with previous
observations [18].
Alternatively, the effect of caveolin-1 on FA turnover was
evaluated in nocodazole-treated cells. Disruption of microtubules
with nocodazole is known to trigger enhanced/synchronized FA
formation in a reversible manner [34]. Thus, B16-F10 cells were
incubated with nocodazole in order to induce FA formation and
the kinetics of FA disassembly was evaluated upon nocodazole
removal. As shown, expression of caveolin-1 promoted FA
disassembly after 120 minutes of nocodazole removal (Figure 6C)
and significantly enhanced the kinetics of turnover when
compared with mock cells (Figure 6D). Importantly, these events
depended on the presence of tyrosine-14, as expression of non-
phosphorylatable caveolin-1 (mutant Y14F) failed to enhance FA
turnover after nocodazole removal (Figure 6E, Figure S4).
These observations were further evaluated in MDA-MB-231
cells. As anticipated, the time required for FA disassembly
increased, whereas FC lifetime decreased upon down-regulation
of caveolin-1 by shRNA (Figure 6F). Similarly, FAs disassembled
in both shRNA-control and shRNA-caveolin-1 cells upon
nocodazole removal; but a significant delay in FA disassembly
was observed in cells treated with shRNA targeting caveolin-1
(Figure 6G). Indeed, both the parameters, half-life (t1/2 shRNA-
control=7 min; t1/2 shRNA-caveolin-1=10.5min) and initial
velocity (V0 shRNA-control=-1.2 FA/min/cell; V0 shRNA-ca-
veolin-1=-0.6 FA/min/cell) were altered by caveolin-1 depletion
in these cells.
Rather intriguingly, after extended periods following nocoda-
zole removal (. 60 min), an increase in FA number was observed
only in caveolin-1 expressing cells (shRNA-control), further
suggesting that caveolin-1 is involved in FA assembly (Figure 6G).
To test this hypothesis, FAs were allowed to accumulate in cells by
treatment with nocodazole. Then the reagent was removed by
changing the medium (wash out), which permits evaluating the
maximum rate of FA disassembly (45 min after removal). Cells
were then pulsed with serum for different periods of time, in order
to induce FA formation, and FAs were quantified (more details in
the Materials and Methods). As anticipated, caveolin-1 depletion
delayed the kinetics of FA assembly (Figure 6H) in MDA-MB-231
cells. In addition, as for disassembly, both parameters of FA
assembly, half-life (t1/2 shRNA-control=17 min; t1/2 shRNA-
caveolin-1=20 min) and initial velocity of assembly (V0 shRNA-
control=0.34 FA/min/cell; V0 shRNA-caveolin-1=0.21 FA/
min/cell) were altered upon caveolin-1 depletion in these cells.
Collectively, results obtained in MDA-MB-231 and B16-F10 cells
indicate that caveolin-1 modulates FA dynamics, both at the level
of assembly and disassembly. Additionally, caveolin-1 seems also
to impact on FC stability, as shown in metastatic cancer cells
(Figures 6B, F) and MEFs [18].
Effect of Caveolin-1 on the Rho-GTPase Balance of
Metastatic Cells
Caveolin-1 was previously suggested to promote basal RhoA
activation, while decreasing active Rac1 in fibroblasts. This
regulation is thought to be essential for nascent FA stabilization
by providing traction forces [18]. Coordinated activation of both
GTPases is proposed to be essential during cell migration [3,35].
Therefore, we evaluated the kinetics of activation of both RhoA
and Rac1 during cell adhesion and spreading, two early events
associated with cell migration. For these experiments, cells were
seeded on plates covered with the extracellular matrix protein
fibronectin, which favors adhesion in comparison to migration. It
should be noted that expression of caveolin-1 did not affect cell
adhesion to fibronectin in either MDA-MB-231 or B16-F10 cells
(Figure S5). In accordance with previous findings, depletion of
caveolin-1 increased basal Rac1 activity in metastatic MDA-MB-
231 cells, as shown by comparing shRNA-control versus shRNA-
caveolin-1 cells (Figure 7A, time=0 min). Importantly, cell
spreading induced Rac1 activation in a caveolin-1-dependent
Caveolin-1 in Metastatic Cell Migration
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activation (Figure 7A). Moreover, RhoA activation was induced
both in cells expressing or lacking caveolin-1 and no significant
differences were observed during cell spreading (Figure 7B).
Discussion
The role of caveolin-1 in cell migration is controversial. On the
one hand, evidence is available indicating that caveolin-1
promotes migration in a variety of cells including fibroblasts,
endothelial cells and tumor-derived cell lines [11,18,19]. Alterna-
tively, inhibition of migration is observed for astrocytes, endothe-
lial, pancreatic carcinoma and metastatic breast cancer cells
[28,29,30,36]. In metastatic breast adenocarcinoma cells, caveo-
lin-1 presence is associated with reduced extension of cellular
protrusions and migration following stimulation with EGF [30].
Moreover, a recent report suggests that caveolin-1 expression in
B16-F10 mouse melanoma cells decreases cell migration and
experimental metastasis [37]. Alternatively, augmented caveolin-1
expression has been associated with enhanced metastatic potential
Figure 4. Caveolin-1 aminoacid tyrosine-14 is required for directionality and persistence of migration in B16-F10 cells. (A) B16-F10
cells transfected with pLacIOP (mock), pLacIOP-caveolin-1 (WT) or the pLacIOP-caveolin-1/Y14F mutant (Y14F) were treated with 1mM IPTG for
24 hours. Then, cell migration was assessed in a Boyden chamber assay by seeding cells (5610
4) on fibronectin-coated (2 mg/ml) transwell plates and
allowing migration for 2 hours. Cells that migrated to the lower side were detected by crystal violet staining (mean 6 SEM, n=3). *P,0.05. Bottom
panels show total protein extracts, separated by SDS-PAGE (35 mg total protein per lane) and analyzed by Western Blotting. Numbers below panels
indicate relative caveolin-1 levels (caveolin-1/WT=22.061.8, caveolin-1/Y14F=16.663.8; values compared with the mock condition and obtained as
the mean from three independent measurements 6 SEM). (B) Confluent monolayers of B16-F10 cells transfected with pLacIOP (mock), pLacIOP-
caveolin-1 (WT) or pLacIOP-caveolin-1/Y14F (Y14F) were wounded with a pipet tip and recorded by time-lapse video microscopy for 10 hours (12-min
frame interval). Cell tracks were determined as indicated in Figure legend 3B. Tracks of single cells at the wounded edge are shown (upper panel). The
edge of the wound is outlined by a white line. Single cell tracks are shown in a Cartesian coordinate system for each cell type (lower panel). (C) The
mean velocity ( mm/min) was derived from the instant velocity (Figure S3), as described in (D). The persistency and directionality of migration were
obtained as described in Figures 3E and 3F, respectively. Data shown are the mean 6 SEM (n=3). *P,0.05.
doi:10.1371/journal.pone.0033085.g004
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ability to enhance migration correlates with polarization and
accumulation of the protein at the rear end of migrating cells [3].
As a first step towards characterizing better the role of caveolin-1
in metastasis, we evaluated the impact of expression of this protein
on the migration of two metastatic cell lines of different origin.
Our findings in both human breast cancer (MDA-MB-231) and
mouse melanoma (B16-F10) cells support the notion that caveolin-
1 enhances polarization, directional migration and persistency of
metastatic cells. However, rather surprisingly, this was achieved
without any apparent redistribution or accumulation at the cell
rear, although phosphorylation on tyrosine-14 appeared essential.
Previous reports showed that caveolin-1 redistribution and
localization at the rear of migrating cells is essential for fibroblast
migration [21,23]. In migrating endothelial cells, caveolin-1 co-
localizes with Gaq/11 at sites of calcium entry implicated in
calpain activation required for FA disassembly and rear end
retraction of cells [9]. Alternatively, some studies have suggested
that the pool of caveolin-1 relevant for migration is phosphory-
lated on tyrosine-14 and located at the leading edge of migrating
cells [19]. The interpretation of the latter studies though, is
hampered by the observation that the anti-phospho-caveolin-1
antibody employed recognizes a different protein associated with
FAs in localization experiments [25]. However, mutational
analysis (Y14F mutation of caveolin-1) revealed that phosphor-
ylatable Y14 is responsible for caveolin-1 localization within
structures required for migration, such as lamellipodia and
invadopodia [11]. In any case, our studies analyzing bulk
caveolin-1 distribution suggest that neither polarization nor
accumulation of caveolin-1 at the rear end or the leading edge is
required in migrating metastatic cells.
This inability to detect protein re-distribution could be
attributed to high expression levels of caveolin-1 in the cells
analyzed. However, we consider this an unlikely possibility for at
least two reasons. First, caveolin-1 levels in the two metastatic
model cell lines employed were comparable to those detected in
NIH3T3 fibroblasts and DITNC1 astrocytes, where we did see
changes in caveolin-1 distribution upon migration (see Figure 1).
Second, we also did not see any degree of polarization in caveolin-
1 distribution for the non-IPTG induced B16-F10(cav-1) cells or
even the B16-F10(mock) cells, which have very low endogenous
levels of expression. Likewise, in the MDA-MB-231 cells, where
endogenous caveolin-1 expression was reduced using a shRNA
approach, no polarization of the residual protein was detectable.
Despite this evidence, we cannot completely exclude the possibility
that redistribution of a minor, functionally relevant pool may have
gone undetected, in our studies. Alternatively, understanding how
a key molecule like caveolin-1 participates in a process that
requires polarization without itself being or becoming polarized is
an enigma that will require further studies to be resolved.
Caveolin-1 effects on metastatic cell migration (this study) are
reminiscent of those observed in fibroblasts [18]. Conversely,
recent findings by Trimmer et al [37] suggest that caveolin-1
expression in B16-F10 mouse melanoma cells reduces migration.
These discrepancies may be attributable to the experimental
approaches used in the two studies. For instance, in this study we
evaluated intrinsic cell migration rather than chemotaxis. Also,
different approaches were employed to overexpress caveolin-1 in
B16-F10 cells. The possibility that our results might be attributable
to the nature of the expression system in B16-F10 cells can be
ruled out as caveolin-1 dependent effects were observed in both
low and high caveolin-1 expressing cells (IPTG absence or
presence). Additionally, the validity of our results in B16F10 cells
was confirmed by the observations in MDA-MB-231 cells where
Figure 5. Inhibition of Src family kinases decreases cell
migration and phosphorylation of caveolin-1 on tyrosine-14.
(A) MDA-MB-231 cells stably transduced with shRNA either targeting
Luciferase (sh-ctrl) or caveolin-1 (sh-cav1) were pre-incubated with
DMSO (D) or 10 mM PP2 for 30 minutes, wounded with a pipet tip,
stimulated (+) or not (-) with 3% of serum and images were recorded at
0 and 16 hours post-wounding. The wounded area was measured with
the Image J software and the percentage of wound closure was plotted
(upper panel). Total protein extracts were prepared and analyzed by
Western blotting with antibodies against caveolin-1, pY14-caveolin-1
and actin. (B) Confluent monolayers of B16-F10 cells transfected with
either pLacIOP or pLacIOP-caveolin-1 were pre-incubated with 1 mM
IPTG for 24 hours. Then, cells were treated with DMSO (D) or PP2,
wounded with a pipet tip, stimulated with 3% of serum and analyzed at
0 and 7 hours post-wounding, as described in (A). Total protein extracts
were prepared and analyzed by Western blotting. Values in (A) and (B)
were averaged from 3 independent experiments (mean 6 SEM).
*P,0.05.
doi:10.1371/journal.pone.0033085.g005
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e33085Figure 6. Caveolin-1 enhances focal adhesion turnover in metastatic cells. (A) B16-F10 cells transfected with pLacIOP (mock) or pLacIOP-
caveolin-1 (cav1) were transfected with pEGFP-vinculin for 24 hours, seeded on fibronectin-coated coverslips (2 mg/ml) and grown in the presence of
1 mM IPTG for 24 hours (see Materials and Methods). Then, cells were serum-starved for 4 hours, pulsed with 10% serum and recorded by time-lapse
video microscopy for 60 minutes (1-min frame interval). Zoomed areas are shown at selected times for mock and cav1 cells. Focal adhesions (FA,
arrows) and focal contacts (FC, arrowheads) were defined by size. Images are representative of 3 independent experiments. (B) Kinetics of FAs and
FCs were measured from experiments shown in A. FA disassembly and FC lifetime were measured for at least 6 structures per experiment (mean 6
SEM, n=3). *P,0.05. (C) B16-F10 mock or cav1 cells were seeded onto fibronectin-coated coverslips (2 mg/ml), grown in the presence of 1 mM IPTG
for 24 hours and treated with 10 mM nocodazole in serum-free medium for 4 hours. Then, nocodazole was removed by wash-out with serum-free
medium and cells were incubated by 0–20 minutes at 37uC. Subsequently, cells were fixed and stained with anti-vinculin antibody (red) and DAPI
(blue) to label FAs and nuclei, respectively. (D) FAs were quantified from experiments described in (C) by using the Image J software. At least 10
images per time point were analyzed. Data were averaged from three independent experiments (mean 6 SEM, n=3). (E) B16-F10 mock (-), cav1 (WT)
or cav1/Y14F (Y14F) cells were treated with 10 mM nocodazole, as described in Figure 6C. Nocodazole was subsequently washed-out for 60 minutes
and FAs were analyzed with an anti-vinculin antibody (red) and nuclei with DAPI (blue). FAs were quantified as in (D). Data are representative from
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essentially the same conclusions.
Using MEFs from knock-out mice, caveolin-1 is shown to be
essential for morphology, polarization and directional migration of
these cells. The ability to do so in these cells is associated with
changes in the activity of small G-protein family members. Thus,
fibroblasts from knock-out mice reportedly have reduced Rho, but
elevated Rac and Cdc42 activity. Indeed, caveolin-1 has been
shown to regulate Src/p120rhoGAP and it has been suggested
that this mechanism might contribute to caveolin-1-mediated
control of small GTPase activity [18]. Besides the differences
concerning polarization, others are apparent when comparing our
results with those observed in fibroblasts models. First, caveolin-1
down-regulation in MDA-MB-231 cells did not affect significantly
the kinetics of RhoA activation, whereas rather strikingly, Rac1-
GTP loading increased upon attachment and cell spreading.
Possibly, variations in the velocity of migration of these cells might
be linked to such differences, given that MEF-3T3 fibroblasts and
DI-TNC1 cells migrate slowly, while both MDA-MB-231 and
B16-F10 cells are rapidly migrating cells. Corroborating this
intriguing possibility will, however, require further research.
Alternatively, it should be mentioned that the observed
differences may also be attributed to experimental settings.
Previously reported data suggesting that Rho-GTPase activity
increases in the presence of caveolin-1 were obtained with cells
maintained in culture [18]. In our studies, on the other hand, we
were interested in understanding the role of caveolin-1 in the
initial stages of cell migration. Thus, enhanced caveolin-1-
mediated activation of Rho-GTPases observed here may reflect
the fact that cells freshly spreading on fibronectin were evaluated.
In this context, it is important to note that cell adhesion to
extracellular matrix proteins (i.e. fibronectin) did not depend on
caveolin-1 expression in either MDA-MB-231 or B16-F10 cells,
excluding the possibility that changes in migration were associated
with differences in adhesion (Figure S5).
Another possibility that may help explaining apparent differ-
ences between previous reports and this study relates to the
dynamics of FA turnover. Rapidly migrating cells assemble very
transient FAs, whereas in slowly migrating cells FAs are larger and
more stable. Such FAs are also a hallmark of adherent fibroblasts.
With this in mind, we predicted that both MDA-MB-231 and
B16-F10 cells should form relatively transient FAs that turnover
even faster in the presence of caveolin-1. Indeed, caveolin-1
increased the kinetics of FA assembly and disassembly in both cell
lines. FAK is widely considered a key regulator of FA dynamics
[33]. Thus, our findings are in general agreement with data
showing changes in FAK dynamics at FAs upon caveolin-1
expression [24].
Increased stability of FCs has been documented for fibroblasts
upon caveolin-1 expression [18]. For both MDA-MB-231 and
B16-F10 cells, a similar, but less pronounced increase in FC
lifetime was linked to caveolin-1 expression. Again, these
variations might be attributable to intrinsic cell properties, such
as their speed of migration. Thus, in future studies, it will be
three independent experiments (mean 6 SEM). *P,0.05. (F) MDA-MB-231 cells stably transduced with shRNA either targeting Luciferase (sh-ctrl) or
caveolin-1 (sh-cav1) were transfected with pEGFP-vinculin for 24 hours, serum-starved for 4 hours, pulsed with 10% serum and recorded by time-
lapse video microscopy, as described in (A). FA disassembly and FC lifetime were measured for 5 structures per experiment. Data were averaged from
three independent experiments (mean 6 SEM, n=3). (G) Focal adhesion disassembly was measured after nocodazole removal in MDA-MB-231 cells
treated with shRNA targeting luciferase (sh-ctrl) or caveolin-1 (sh-cav1), as described in (C) and (D). Data were averaged from 12 measurements (mean
6 SD). Data are representative of two independent experiments. (H) FA assembly was evaluated as described in the Materials and Methods. MDA-MB-
231 cells were treated with 10 mM nocodazole for 4 hours and subsequently washed-out for 45 min. Then, cells were pulsed with 10% serum for the
indicated periods of time and FAs were evaluated as described in (D). Data were averaged from 12 measurements (mean 6 SD). Data are
representative of two independent experiments.
doi:10.1371/journal.pone.0033085.g006
Figure 7. Effects of caveolin-1 on Rho-GTPases in MDA-MB-231
cells. (A) Kinetics of Rac1 activation upon spreading. MDA-MB-231
cells, stably transduced with shRNA either targeting Luciferase (sh-ctrl)
or caveolin-1 (sh-cav1), were allowed to attach/spread onto fibronectin-
coated plates (2 mg/ml) for different periods of time. Cell extracts were
prepared and Rac1-GTP levels were measured by using the GST-PBD
pull down assay, as indicated in the Materials and Methods. Rac1-GTP
levels were normalized to total Rac1 by scanning densitometry. Data
were averaged from three independent experiments (mean 6 SEM).
*P,0.01; **P,0.05. (B) RhoA activity was measured by the GST-RBD
pull down assay in cells induced to spread onto fibronectin at different
time points, as in (A). Data were averaged from three independent
experiments (mean 6 SEM).
doi:10.1371/journal.pone.0033085.g007
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level these FA structures in slowly and rapidly migrating cells.
Caveolin-1 is known to be phosphorylated by Src, Fyn (SFKs) or
Abl under stress conditions, for example, following exposure of
cells to H2O2 [40]. SFKs are also well-known regulators of cell
migration [1,3] and their inhibition reportedly affects FA turnover.
Moreover, previous reports employing pharmacological and
mutational approaches suggest that the phosphorylation of
tyrosine-14 is essential for caveolin-1-mediated control of cell
polarization, migration and FA dynamics [11,17,24]. Consistent
with these published results, mutation of tyrosine-14 (Y14F
mutant) ablated the ability of caveolin-1 to enhance FA turnover
and to promote migration of B16-F10 cells. Alternatively,
pharmacological inhibition of SFKs with the inhibitor PP2 in
MDA-MB-231 cells coincided with reduced migration and the loss
of caveolin-1 phosphorylation on tyrosine-14, again suggesting the
requirement of this residue and phosphorylation thereof for
caveolin-1-driven migration.
Caveolin-1 phosphorylation was previously associated with FA
turnover by indirect measurements that assessed FAK stabilization
at FAs [24,41]. In addition, fluorescence recovery after photo-
bleaching analysis suggested that FAK and FA regulation by
caveolin-1 represent part of a feedback loop that involves Rho,
ROCK, and Src [11]. In doing so, caveolin-1 was suggested to
promote directional migration and changes in the Rho GTPase
balance. Our results coincide in this respect by implicating SFK-
dependent caveolin-1 phosphorylation in FA turnover in meta-
static cells.
Caveolin-1 phosphorylation is implicated in promoting the
translocation of Csk to caveolae and subsequent inactivation of Src
and actin reorganization that could be related to the role of
phospho-caveolin-1 in FA turnover and directional cell migration
[31,42]. Our results suggest that SFK activity is necessary for
caveolin-1 phosphorylation and cell migration, but also that SFKs
affect cell migration in a caveolin-1-independent manner, since
cells with decreased caveolin-1 expression [shRNA-caveolin-1 in
MDA-MB-231 cells and B16-F10 (mock) cells] showed a basal
migration rate that was sensitive to PP2. Given that PP2 is a
selective rather than a specific inhibitor, the identity of the specific
SFK involved in caveolin-1 phosphorylation during metastatic cell
migration remains to be established.
Finally, caveolin-1 expression has been associated with
metastasis of tumor cells, including prostate, breast and colon
carcinomas. A plethora of mechanisms have been proposed, such
as autocrine/paracrine regulation, elevated angiogenesis and
multi-drug resistance amongst others [14,15]. Indeed, some
metastatic features have also been linked to caveolin-1, as its
expression increases invasion and the biogenesis of invadopodia
[13], and regulates MT1-MMP function within these structures
[43]. In this regard, more experiments are required to assess the
requirement of this critical tyrosine-14 for caveolin-1-enhanced
metastasis. Indeed, preliminary data suggest that mutation of this
residue to phenylalanine compromises caveolin-1-enhanced me-
tastasis of B16-F10 cells to the lungs of C57/BL6 mice (Lobos and
Quest, data not shown). Thus, caveolin-1-enhanced migration
described here for metastatic cells in vitro appears to correlate well
with their behavior anticipated in vivo.
In summary, we show here that caveolin-1 expression enhances
velocity, directionality and persistency of migration of metastatic
cancer cells and that this effect depends on the presence of
tyrosine-14. Unexpectedly, and in striking contrast to previous
reports, polarization of caveolin-1 did not appear to be necessary.
Since two metastatic (breast and melanoma) cell types from
different species (human and mouse) were characterized in a
variety of settings, our observations have broad implications for
the role of caveolin-1 in rapidly migrating cells and cancer.
Materials and Methods
Antibodies and Reagents
Rabbit polyclonal antibodies anti-caveolin-1 (Transduction
Laboratories, Lexington, KY), anti-actin (R&D Systems, Minne-
apolis, MN) and anti-Gigantin-1 (Covance, Princeton, NJ), as well
as the mouse monoclonal antibodies anti-pY14-caveolin-1 (Trans-
duction Laboratories, Lexington, KY), anti-caveolin-1 (Transduc-
tion Laboratories, Lexington, KY) and anti-Golgin97 (Molecular
probes, Eugene, OR) were used as indicated by the manufacturers.
Goat anti-rabbit and goat anti-mouse IgG antibodies coupled to
horseradish peroxidase (HRP) were from Bio-Rad Laboratories
(Hercules, CA) and Sigma-Aldrich (St. Louis, MO), respectively.
Alexa Fluor 488 goat anti-mouse IgG and Alexa Fluor 546 goat
anti-rabbit IgG were from Molecular Probes. DAPI was from
Sigma-Aldrich. Cy3-coupled goat anti-mouse, fluorescein isothio-
cyanate-coupled goat anti-rabbit and Cy5-coupled goat anti-rabbit
IgG were from Jackson Immunoresearch (West Grove, PA). The
EZ-ECL chemiluminescent substrate was from Biological Indus-
tries (Kibbutz Beit Haemek, Israel). The BCA protein determina-
tion kit was from Pierce (Rockford, IL). The Plasmid Midi Kit was
from Qiagen (Valencia, CA). Hygromycin was from Calbiochem
(La Jolla, CA). Fetal bovine serum (FBS) was from Biological
Industries and Hyclone. Cell culture media and antibiotics were
from GIBCO (Invitrogen). PP2 was from Enzo Life Science
International (Plymouth Meeting, PA). All other reagents were
from Sigma-Aldrich or of the highest grade available.
Cell Culture
The rat astrocytic cell line DI-TNC1 (ATCC, #CRL-2005) was
maintained in RPMI 1640 medium containing 5% FBS (Fetal
Bovine Serum), 0.1 mM 2-mercaptoethanol and antibiotics
(100 U/mL penicillin and 100 mg/mL streptomycin). Human
breast cancer cells MDA-MB-231 (ATCC, #HTB-26) were
maintained in DMEM-F12 medium containing 10% FBS and
antibiotics. Mouse embryonic fibroblasts MEF-3T3 (ATCC,
#CRL-2752) were maintained in DMEM medium supplemented
with 10% FBS and antibiotics. Metastatic murine melanoma cells
B16-F10 (ATCC, #CRL6475) were maintained in RPMI 1640
medium supplemented with 10% FBS and antibiotics. Human
embryonic kidney 293T cells (HEK293T, ATCC, #CRL-11268)
were maintained in DMEM high glucose supplemented with 10%
FBS and antibiotics. Cells were cultured at 37uC and 5% CO2.
Transfection of B16-F10 Melanoma Cells
The plasmids pLacIOP and pLacIOP-caveolin-1 were previ-
ously described [26]. B16-F10 cells were grown to 60-80%
confluence in 10-cm plates and then electroporated with 25 mgo f
pLacIOP or pLacIOP-caveolin-1 plasmids in RPMI medium
without serum using a pulse of 270 V and 1,600 mF in a cell
Porator (GIBCO, Invitrogen). After electroporation, cells were
plated in complete RPMI medium containing hygromycin
(750 mg/mL) for 2 to 3 weeks to yield stably transfected B16-
F10(mock) and B16-F10(Cav-1) cells, respectively.
Lentiviral shRNA, Constructs and Stable Knockdown of
Caveolin-1
The oligonucleotide containing shRNA candidates for caveolin-
1( #1-1, CCAGTTAGATTTAGGGATTTA; #1-2,
CCGCTTGTTGTCTACGATCTT; #1-3, CGACGTGGT-
CAAGATTGACTT; #1-4, TGAAGCTATTGGCAAGA-
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control shRNA for Luciferase (CGCTGAGTACTTC-
GAAATGTC) were cloned into the lentiviral vector pLKO.1,
which contains a puromycin resistance gene and the U6 promoter
to control the shRNA. Lentiviral particles were prepared by co-
transfecting HEK-293T cells (packaging) with the pLKO.1 vector
and plasmids encoding the envelope protein VSV-g (pHCMV-G)
and the packaging plasmid p?8.9 (pCMV?R8.9) as described [44].
Post-transfection (48 hours), media containing lentivirus were
filtered through a 0.45 mm filter and used to transduce MDA-MB-
231 cells in the presence of 8 mg/ml polybreen. After 24 hours
cells were selected with puromycin (2mg/ml) for seven days and
expression was monitored by Western blotting. Plasmids encoding
the envelope protein VSV-g (pHCMV-G), the packaging plasmid
p?8.9 (pCMV?R8.9) and pLKO.1 plasmids containing shRNA for
caveolin-1 and control plasmid containing shRNA for Luciferase
(shLuc) were provided by Dr. Claudio Hetz (Universidad de Chile,
Santiago, Chile).
Site Directed Mutagenesis of Caveolin-1
The Y14F mutation was introduced by double PCR, using the
primers 59 - cct ctt tac cgt tcc cat cc - 39 (sense) and 59 - gaa cgg taa
aga ggt gcc c - 39 with sequence overlap in the region
encompassing the codon for tyrosine 14. External primers used
to amplify the full-length caveolin-1 sequence were: 59-ccg agc gcg
gcc gcc atg tct ggg ggc aaa tac-39 (sense) and 59-tat ctg gcg gcc gct
tat gtt tct ttc tgc atg ttg-39 (anti-sense), both harboring NotI sites.
After a double PCR reaction, the final PCR product was cloned
into pcDNA3.1(+) following digestion with a BamHI/EcoRI.
Positive colonies were identified and sequenced in both directions.
The caveolin-1-encoding sequence with the Y14F mutation was
then sub-cloned from pcDNA3.1(+) into the multiple cloning site
of pLacIOP, by digesting with NotI. Correct orientation of the
insert was determined by PCR using an external anti-sense primer
targeting the vector (59-gat gaa gaa ttc tta tgt ttc ttt ctg cat gtt g-39)
in combination with the sense primer used to generate the Y14F
mutation.
Western Blotting
Cells grown to 80% confluence were washed twice with cold
PBS and lysed in 0.2 mM HEPES (pH 7.4) buffer containing
0.1% SDS, phosphatase inhibitors (1 mM Na3VO4) as well as a
protease inhibitors cocktail (10 mg/mL benzamidine, 2 mg/mL
antipain, 1 mg/mL leupeptin, 1 mM PMSF). Protein concentra-
tion was determined by the BCA assay. Total protein extracts
(30 mg/lane) were separated by SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE). Separated proteins were then transferred to
nitrocellulose membrane. Blots were blocked with 5% milk in
0.1% Tween-PBS and then probed with anti-actin (1:5000), anti-
caveolin-1 (1:5000) polyclonal antibodies or blocked with 5%
Gelatin in 0.1% Tween-PBS for incubations with anti-pY14-
caveolin-1 (1:3000) monoclonal antibody. Bound antibodies were
detected with HRP-conjugated secondary antibodies and the EZ-
ECL system.
Immunofluorescence Labeling and Cell Polarization
Assay
Confluent cell monolayers grown on 12-mm coverslips in 24-
well plates were injured with a 20-200 ml pipette tip, washed twice
with PBS and subsequently RPMI 1640 with 3% FBS was added.
Cells were fixed at different time points with 4% paraformalde-
hyde in 100 mM PIPES buffer pH 6.8, containing 40 mM KOH,
2 mM EGTA and 2 mM MgCl2 for 30 minutes. Afterwards, cells
were washed three times with washing solution (50 mM Tris
buffer pH 7.6 containing 0.15N NaCl and 0.1% sodium azide).
Cells were permeabilized with 0.1% Triton X-100 in washing
solution for 10 min, washed twice and then blocked with 1%
bovine serum albumin for 60 min. Caveolin-1 polarization was
evaluated by staining cells with an anti-caveolin-1 pAb (1:200),
followed by FITC-conjugated anti-rabbit IgG (1:200). Cell
polarization was monitored by staining with anti-Golgin97 mAb
and anti-caveolin-1 pAb followed by rhodamine-coupled anti-
mouse IgG and FITC-coupled anti-rabbit IgG for MDA-MB-231
cells, and anti-Gigantin-1 pAb followed by Cy5-coupled anti-
rabbit IgG for B16-F10 cells. FITC-coupled phalloidin was used to
stain polymerized actin. Either DAPI (0.5 mg/mL) or Propidium
Iodide (10 mg/mL) were used for nuclear staining. Coverslips were
washed and mounted on microscope slides with 10% Mowiol-
2.5% 1,4-Diazabicyclo [2.2.2]octane and samples were visualized
with a LSM Microsystems Pascal 5 confocal microscope (Carl
Zeiss, Thornwood, NY).
Caveolin-1 polarization was evaluated in the first layer of cells
lining the wounded area by scoring for Golgi orientation towards
the wound. Eight equal regions were defined within each cell
analyzed, four regions at the cell front and four at the rear, with
respect to the nucleus. Fluorescence intensity was measured with
the Image J software and the ratio of rear-to-front fluorescence
intensity was calculated [21]. Cells harboring polarized caveolin-1
were defined as cells with a fluorescence intensity ratio 2 fold S.D.
greater than the mean at time 0 min. Cell polarization was
evaluated as the percentage of cells along the border of the wound
that show reoriented Golgi with respect to the nuclei. Cells were
considered polarized, when the Golgi was perinuclear and
oriented towards the wounded area.
Time-Lapse Video Microscopy
For cell migration track analysis, confluent monolayers were
wounded with a 20-200 ml pipette tip. Cells were washed twice
with PBS and subsequently RPMI 1640 with 3% FBS was added.
Image series were acquired using a 10X objective lens in an
inverted microscope (Leica TCS SP) heated with an airstream
incubator at 37uC. Images were captured using a CCD
Hamamatsu camera. Image processing and analysis was per-
formed with the Image J software (Plugin ‘‘Manual Tracking’’).
The velocity of migration was measured as the instant velocity
of each cell at any given time point. Cell persistency was quantified
as the ratio of the net distance divided by the total distance of
movement (ID) for each cell. Directionality of cell migration (cell
orientation) was evaluated with the Image J Software (plugin
‘‘chemotaxis’’) by placing cell tracks in a Cartesian coordinate
system. Cell tracks that remained within a 60u angle with respect
to the direction of cell movement were considered as directional.
Vinculin is an intermediate filament protein that is recruited to
FAs as they form and then degraded as these structures
disassemble [45]. Thus, to evaluate FA turnover, cells were
transiently transfected with plasmid encoding vinculin-GFP
(pEGFP-vinculin, kindly donated by Kris DeMali, University of
Iowa [46]). Post-transfection (24 hours), cells were re-plated onto
22 mm coverslips, grown for 24 hours in complete medium
followed by 4 hours starvation and then stimulated (pulsed) with
10% FBS. Cells were visualized in a spinning disk confocal
microscope (IX81, Olympus) and a 12-bit CCD camera (XM10,
Olympus). Images were captured at time intervals of 1 minute for
1 hour. For the analysis of FAs and FCs, we first defined these
structures in function of size with the Image J software. GFP-
positive structures ranging from 20 to 850 relative pixels were
screened and the cut-off was made as follows: 20-100 relative
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pixels were referred to as FAs (average relative pixels were 49 and
388 for FCs and FAs, respectively). FA turnover and half life was
evaluated from time-lapse image series, by quantifying the
intensity of pixels of nascent focal adhesions (focal contacts, FCs)
and mature focal adhesions (FAs) with the Image J software.
Focal Adhesion Assembly and Disassembly Assay
Cellsweregrownonglasscoverslipsfor24hoursandthentreated
with 10 mM nocodazole in serum-free medium for 4 hours to
depolymerize microtubules, as previously described [34]. Nocoda-
zole was washed out with serum-free medium and cells were
incubated at 37uC for the indicated periods of time. Subsequently,
cellswerefixedandthenpreparedforimmunofluorescencestaining,
as indicated above. FAs were identified with anti-vinculin antibody;
actin was stained with phalloidin and nuclei with DAPI. Samples
were visualized using spinning disk confocal microscopy (IX81,
Olympus) and a 12-BIT CCD camera (XM10, Olympus). Images
were processed after subtracting threshold levels due to diffuse
vinculin staining. For evaluation of assembly and disassembly, FAs
werequantifiedatalltimepoints(totalnumber).Fluorescencepixels
due to vinculin accumulated in punctate structures was normalized
with respect to the number of cells analyzed.
Transwell Migration Assay
Assays were performed in Boyden Chambers (Transwell Costar,
6.5 mm diameter, 8 mm pore size) according to the manufacturer’s
instructions. Briefly, the bottom sides of the inserts were coated
with 2 mg/ml fibronectin. Cells (5610
4) re-suspended in serum-
free medium were plated onto the top of each chamber insert and
serum-free medium was added to the bottom chamber. After 2
hours, inserts were removed, washed and cells that migrated to the
bottom side of the inserts were stained with 0.1% crystal violet in
2% ethanol and counted in an inverted microscope.
Adhesion Assay
Cellsweresuspendedinserum-freemediumandallowedtoattach
to fibronectin coated-24 well plates (2mg/ml) at different periods of
time as indicated. Non-adherent cells were removed by washing
gently in serum-free medium and adherent cells were stained with
0.1% crystal violet in 2% ethanol. Cell-bound dye was eluted with
methanol, and the absorbance was measured at 600 nm.
Rac-GTP and RhoA-GTP Pull Down Assay
Cells were allowed to attach to fibronectin coated plates (2 mg/
ml) for different periods of time and subsequently lysed in a buffer
containing 25 mM HEPES (pH 7.4), 100 mM NaCl, 5 mM
MgCl2, 1% NP40, 10% glycerol, 1 mM dithiothreitol and
protease inhibitors. Extracts were incubated for 5 minutes on ice
and clarified by centrifugation (10,0006g, 1 min, 4uC). Post-
nuclear supernatants were used for pull down assays with 30 mgo f
GST-PBD (Rac1) or GST-RBD (RhoA) pre-coated GSH beads
per condition. Beads were incubated with supernatant for 15
minutes at 4uC in a rotating shaker. Thereafter, beads were
collected, washed with lysis buffer containing 0.01% NP40 and
samples were solubilized in sample buffer, boiled and separated by
SDS PAGE for analysis by Western blotting as indicated above.
Statistical Analysis
Results were statistically compared using the Kruskal-Wallis
ANOVA test followed by multiple comparison posttests (Dunn’s
multiple comparison test). For paired groups the Mann-Withney
test was employed. Data analyzed in this manner are specifically
indicated in the respective Figure legends. All groups were from
three or more independent experiments. P,0.05 was considered
significant.
Supporting Information
Figure S1 MDA-MB-231 cell polarization. (A) Total
protein extracts were prepared from parental MDA-MB-231
and cells stably transfected with a control shRNA targeting
luciferase (sh-ctrl) or different shRNA sequences targeting
caveolin-1 (sh cav1, #1-3 or #1-5). Extracts were separated by
SDS-PAGE (35 mg total protein per lane) and analyzed by
Western Blotting with antibodies against caveolin-1 and b actin.
(B) Confluent monolayers of parental, shRNA-control (sh-ctrl) or
shRNA-caveolin-1 (sh-cav1, #1-5) treated MDA-MB-231 cells
were wounded with a pipet tip and fixed at 0 (left panel) and 60
min (right panel) after monolayer injury. Samples were stained
with anti-Golgin-97 (red) antibody and the nuclei were stained
with DAPI (blue). The edge of the wound is outlined by a white
line. Scale bar, 20 mm. (C) Confluent monolayers of shRNA-
caveolin-1 (sh-cav1, #1-3) treated MDA-MB-231 cells were
analyzed as in (A) and stained with anti-Golgin-97 (red) antibody
and the nuclei were stained with DAPI (blue).
(TIF)
Figure S2 B16-F10 cell polarization. B16-F10 cells trans-
fected with either pLacIOP (mock) or pLacIOP-caveolin-1 (cav1)
were treated or not with 1 mM IPTG for 24 hours, grown in
monolayers and wounded with a pipet tip to allow migration for
1 hour. Samples were stained with anti-Gigantin-1 polyclonal
antibody (blue) and propidium iodide (red). The edge of the
wound is outlined by a white line. Scale bar, 20 mm.
(TIF)
Figure S3 Effect of caveolin-1 on B16-F10 cell migration.
(A) B16-F10 cells transfected with pLacIOP (mock, open triangles),
pLacIOP-caveolin-1 (WT, filled diamonds) or the pLacIOP-
caveolin-1/Y14F mutant (Y14F, gray circles) were treated with
1 mM IPTG, grown as confluent monolayers and wounded with a
pipette tip. Migration was recorded by time lapse video
microscopy (total hours, 12 min frame interval) and cell tracks
were determined by using the Image J software (‘‘Manual
Tracking’’ plug-in) (shown in Figure 4B). Instant velocity was
analyzed for each cell type in Figure 4B and plotted as a function
of time (0–10 hours). (B) B16-F10 cells transfected with pLacIOP
(mock), pLacIOP caveolin 1/Y14F mutant (Y14F), or a clone
(clone 3) obtained from cells transfected with pLacIOP caveolin 1
(WT) (described in Figure 4) were treated with 1mM IPTG for
24 hours. Then, cell migration was assessed in a Boyden chamber
assay by seeding cells (56104) on fibronectin coated (2 mg/ml)
transwell plates and allowing migration for 2 hours. Cells that
migrated to the lower side were detected by crystal violet staining.
Bottom panels show total protein extracts, separated by SDS
PAGE (35 mg total protein per lane) and analyzed by Western
Blotting. Data are representative of two independent experiments.
(TIF)
Figure S4 Effect of the caveolin-1/Y14F mutant on focal
adhesion disassembly. B16-F10 cells transfected with either
pLacIOP (mock) or pLacIOP-caveolin-1/Y14F mutant (Y14F)
were seeded onto fibronectin-coated coverslips (2 mg/ml), grown
in the presence of 1 mM IPTG for 24 hours and treated with
10 mM nocodazole in serum-free medium for 4 hours. Then,
nocodazole was removed by wash-out with serum-free medium
and cells were incubated by 0 and 60 min at 37uC. Subsequently,
cells were fixed and stained with anti-vinculin antibody (red) and
Caveolin-1 in Metastatic Cell Migration
PLoS ONE | www.plosone.org 13 April 2012 | Volume 7 | Issue 4 | e33085DAPI (blue) to label FAs and nuclei, respectively. Images shown
are representative of results from three independent experiments.
FAs were quantified by using the Image J software (see Figure 6E).
(TIF)
Figure S5 Effect of caveolin-1 on cell adhesion. MDA-
MB-231 cells treated with shRNA-control (ctrl) or shRNA-
caveolin-1 (sh-cav1) and B16-F10 cells transfected with pLacIOP
(mock) or pLacIOP-caveolin-1 (cav1) were held in suspension and
allowed to attach to fibronectin-coated plates (2 mg/ml). Cell
adhesion was monitored at different time points by crystal violet
staining. Data are representative of two independent experiments
in triplicate (mean 6 SD).
(TIF)
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